Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 19 min ago
Peer-reviewedCC BY 4.0eBioMedicine

Unravelling the biological divergence of CD30+ lymphoproliferative disorders with skin involvement: from clinical risk to precision oncology

  • Yi Jiang
  • Yang Wang
Open at sourceDOICite

Related

  1. Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study
    Leonardo P.A. Biral, Veronica Russell, Maria Angelica Selim +33
    eBioMedicinePeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefPMC
  2. Age, Comorbidity Burden and Treatment Outcomes in Mature B-Cell Lymphoproliferative Disorders: A Real-World Study.
    Kevin Nasrinfar, Harrison Wildhaber, Rudolf Rohr +4
    Cancer medicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  3. Molecular profiling and disease tracking of posttransplant lymphoproliferative disorders using cell-free DNA∗
    Yujie Zhong, Nick Veltmaat, Filipe Montes de Jesus +13
    Blood AdvancesPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  4. Posttransplant lymphoproliferative disorders following hematopoietic stem cell transplantation: a clinicopathological study of a large single-center cohort.
    Jun Lin, Mengyun Zhou, Chang Shen +3
    Annals of hematologyPeer-reviewedCC BYFull textOncologyEurope PMCPMCDOAJ
  5. Immune Background Profiles Across B-cell Lymphoproliferative Disorders
    Thushara Balasuriya, Chamarika Moonesinghe, Neluka Fernando +3
    CureusPeer-reviewedCC BYFull textHuman geneticsEurope PMCEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{jiang2026unravelling,
  title = {{Unravelling the biological divergence of CD30+ lymphoproliferative disorders with skin involvement: from clinical risk to precision oncology}},
  author = {Yi Jiang and Yang Wang},
  journal = {eBioMedicine},
  year = {2026},
  month = oct,
  doi = {10.1016/j.ebiom.2026.106543},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S2352396426004275},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Unravelling the biological divergence of CD30+ lymphoproliferative disorders with skin involvement: from clinical risk to precision oncology
AU  - Yi Jiang
AU  - Yang Wang
PY  - 2026
DA  - 2026/10/30
JO  - eBioMedicine
DO  - 10.1016/j.ebiom.2026.106543
UR  - https://linkinghub.elsevier.com/retrieve/pii/S2352396426004275
SN  - 2352-3964
ER  -